Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

List of USP reference standards related to DSSTox_CID_2927

Client Email

Product

DSSTox_CID_2927
CAS 573-17-1
CAS 5401-94-5
USP

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

Veranova: A CDMO that manages complexity with confidence.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

DSSTox_CID_2927

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

17 API Suppliers, 12 USDMF, 2 CEP/COS, 1 EU WC, 3 NDC API, 5 Listed Suppliers

17 API Suppliers
12 USDMF
2 CEP/COS
1 EU WC
3 NDC API
5 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

77 FDF Dossiers, 29 FDA Orange Book, 24 Europe, 18 South Africa, 6 Listed Dossiers

77 FDF Dossiers
29 FDA Orange Book
24 Europe
18 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SOLUTION;ORAL - 10MG/ML, CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SOLUTION;ORAL - 10MG/ML
CAPSULE, DELAYED REL PELLETS;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, DELAYED REL PELLETS;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, DELAYED REL PELLETS;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, DELAYED REL PELLETS;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 Rochem International Inc, 1 SPI Pharma, 2 Seqens, 9 DKSH, 1 Jai Radhe Sales, 8 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 13 Corel Pharma Chem, 4 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 7 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 15 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 6 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 12 Roquette, 7 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 The Dow Chemical Company, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

61 Coating Systems & Additives, 36 Controlled & Modified Release, 26 Thickeners and Stabilizers, 26 Fillers, Diluents & Binders, 25 Disintegrants & Superdisintegrants, 17 Direct Compression, 14 Granulation, 13 Film Formers & Plasticizers, 13 Solubilizers, 12 Taste Masking, 11 Topical, 9 Empty Capsules, 8 Lubricants & Glidants, 8 Co-Processed Excipients, 6 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Emulsifying Agents, 3 Chewable & Orodispersible Aids, 3 Parenteral, 2 Surfactant & Foaming Agents

61 Coating Systems & Additives
36 Controlled & Modified Release
26 Thickeners and Stabilizers
26 Fillers, Diluents & Binders
25 Disintegrants & Superdisintegrants
17 Direct Compression
14 Granulation
13 Film Formers & Plasticizers
13 Solubilizers
12 Taste Masking
11 Topical
9 Empty Capsules
8 Lubricants & Glidants
8 Co-Processed Excipients
6 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules
4 API Stability Enhancers
4 Emulsifying Agents
3 Chewable & Orodispersible Aids
3 Parenteral
2 Surfactant & Foaming Agents

GLOBAL SALES INFORMATION

8 Finished Drug Prices

8 Finished Drug Prices

MARKET PLACE

1 FDF Dossiers

1 FDF Dossiers

REF. STANDARDS & IMPURITIES

4 EDQM, 4 USP, 4 Others

4 EDQM
4 USP
4 Others

Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

4 All

01 11191204

02 11191215

03 11191226

04 11191237

filter Description Reset all filters

4 All

01 1Didanosine (200 mg)

02 1Didanosine Related Compound A (25 mg) (Hypoxanthine)

03 1Didanosine Related Compound B (25 mg) (2',3'-dideoxyadenosine)

04 1Didanosine System Suitability Mixture (10 mg)

filter CAS Number Reset all filters

4 All

01 14097-22-7

02 168-94-0

03 269655-05-6

EDQM
USP Standards
Others

Product Main Page

01

USP

Boulder Peptide 2024

Not Confirmed

USP

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Didanosine Related Compound B (25 mg) (2',3'-...

CAS Number : 4097-22-7

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1191237

Current Lot : F0G209

Previous Lot :

NDC Code :

Product Web Link

Digital Content

02

USP

Boulder Peptide 2024

Not Confirmed

USP

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Didanosine Related Compound A (25 mg) (Hypoxa...

CAS Number : 68-94-0

Quantity Per Vial :

Price ($) : 805

Catalog Number : 1191226

Current Lot : F0G113

Previous Lot :

NDC Code :

Product Web Link

Digital Content

03

USP

Boulder Peptide 2024

Not Confirmed

USP

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Didanosine System Suitability Mixture (10 mg)

CAS Number : 69655-05-6

Quantity Per Vial :

Price ($) : 730

Catalog Number : 1191215

Current Lot : F0G034

Previous Lot :

NDC Code :

Product Web Link

Digital Content

04

USP

Boulder Peptide 2024

Not Confirmed

USP

Boulder Peptide 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Didanosine (200 mg)

CAS Number : 69655-05-6

Quantity Per Vial :

Price ($) : 1095

Catalog Number : 1191204

Current Lot : F0G088

Previous Lot :

NDC Code :

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?